DNA Test Reveals Drug Response and Fasting Risk That Years of Blood Tests Missed

Nickhil Jakatdar underwent genetic sequencing that uncovered health insights his routine blood tests had failed to detect over eleven years. The analysis showed his body metabolizes rosuvastatin, a common statin medication, more slowly than most people, which will inform his future treatment decisions. His genome also carried a variant linked to Gilbert syndrome, a liver condition affecting bilirubin processing. This finding suggested that prolonged intermittent fasting may not be suitable for him, contrary to its general popularity. Together, these personalized genetic insights allowed him to tailor his healthcare approach with greater confidence.